Hope Rugo, MD, FASCO Archives | OncUpdates

Hope Rugo, MD, FASCO

Author

Hope Rugo, MD, FASCO

City of Hope Comprehensive Cancer Center

Latest Videos

Video

HR+ Metastatic Breast Cancer Updates from SABCS 2025

Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Ep. 4: Ribociclib and the Evolving Role of Oral SERDs in High-Risk Disease

Laura Huppert, MD | Komal Jhaveri, MD, FACP | Heather McArthur, MD | Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Ep. 3: Abemaciclib vs Ribociclib: Clinical Decision-Making for Quality of Life

Laura Huppert, MD | Komal Jhaveri, MD, FACP | Heather McArthur, MD | Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Ep. 2: Metastatic HR-Positive Breast Cancer: Choosing the Right CDK4/6 Inhibitor

Laura Huppert, MD | Komal Jhaveri, MD, FACP | Heather McArthur, MD | Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Ep. 1: Clinical Insights: Optimizing Ribociclib, Abemaciclib, and Palbociclib Use in Metastatic HR-Positive Breast Cancer

Laura Huppert, MD | Komal Jhaveri, MD, FACP | Heather McArthur, MD | Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

CDK4/6 Inhibitor Selection in HR+ Metastatic Breast Cancer (Full Video)

Laura Huppert, MD | Komal Jhaveri, MD, FACP | Heather McArthur, MD | Hope Rugo, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Clinical Impact of DESTINY-Breast09 in HER2+ Breast Cancer Management

Arya Mariam Roy, MD | Hope Rugo, MD, FASCO

Video

Integrating Metastatic Triple-Negative Breast Cancer NCCN Guidelines Into Clinical Practice

Arya Mariam Roy, MD | Hope Rugo, MD, FASCO

Video

ASCENT-04 Trial: First-Line Sacituzumab Govitecan Plus Pembrolizumab Improves PFS in PD-L1+ TNBC

Arya Mariam Roy, MD | Hope Rugo, MD, FASCO